COMMUNIQUÉS West-GlobeNewswire

-
New Nymbl Science Report Asks: Are Falls an Invisible Epidemic?
05/06/2024 -
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024 -
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six Months of Treatment in Late-Breaking Poster Presentation at EASL Congress 2024
05/06/2024 -
InflaRx Hosts R&D Event Highlighting the Promise of INF904
05/06/2024 -
Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024
05/06/2024 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024
05/06/2024 -
Late Breaking Poster Shows a Novel Oral Insulin Sensitizer Azemiglitazone (MSDC-0602K) Could Substantially Preserve Lean Muscle in Combination with Weight-Loss GLP1s
05/06/2024 -
New Findings Revealed on Kyolic Aged Garlic Extract Research at 7th Annual International Garlic Symposium
05/06/2024 -
SupplyCopia Unveils Groundbreaking Real-time Smart Agent, Powered by AI for On-demand Analytics Needed by Healthcare Organizations
05/06/2024 -
XTL Entered Definitive Agreement to Acquire The Social Proxy
05/06/2024 -
Rett Syndrome Research Trust Launches Roadmap to Cures to Advance Next-Generation Genetic Medicines into Clinical Trials
05/06/2024 -
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
05/06/2024 -
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
05/06/2024 -
CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans
05/06/2024 -
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
05/06/2024 -
Safety Shot Partners with Prime CSB to Expand Distribution Into New York and New Jersey
05/06/2024 -
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
05/06/2024 -
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
05/06/2024 -
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
05/06/2024
Pages